O
Live / Applied — Statement of use — final refusal mailed (as of 31 Jul 2026)
Now
Refused — a final office action was mailed 31 Jul 2026.
The response was due 31 Oct 2026. Unless a response reached the USPTO that its records do not show yet, the application will be abandoned.
What this means for you
Not registered yet, but its 12 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98401989
- Mark type
- Design + words
- Filed
- 12 Feb 2024
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions for ophthalmological use; topical anesthetic gel for ophthalmological use
Owner
- Harrow IP, LLC, Nashville, TN, US
- Harrow IP, LLC, Nashville, TN, US
Prosecution history
- 31 Jul 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 31 Jul 2026 — FINAL REFUSAL E-MAILED
- 31 Jul 2026 — SU - FINAL REFUSAL - WRITTEN
- 01 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Jul 2026 — ASSIGNED TO LIE
- 29 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Mar 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 29 Mar 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Dec 2025 — NON-FINAL ACTION E-MAILED
- 29 Dec 2025 — SU - NON-FINAL ACTION - WRITTEN
- 22 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Oct 2025 — USE AMENDMENT FILED
- 22 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL